Investigating the Mechanisms of Hyporesponse to Antiplatelet Approaches

Hyporesponsiveness, or resistance, to antiplatelet therapy may be a major contributor to poorer outcomes among cardiac patients and may be attributed to an array of mechanisms—both modifiable and unmodifiable. Recent evidence has uncovered clinical, cellular, and genetic factors associated with hypo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cardiology (Mahwah, N.J.) N.J.), 2008-03, Vol.31 (S1), p.I21-I27
Hauptverfasser:	Braunwald, Eugene, Angiolillo, Dominick, Bates, Eric, Berger, Peter B., Bhatt, Deepak, Cannon, Christopher P., Furman, Mark I., Gurbel, Paul, Michelson, Alan D., Peterson, Eric, Wiviott, Stephen
Format:	Artikel
Sprache:	eng
Schlagworte:	acute coronary syndromes<ischemic heart disease Aspirin - therapeutic use Blood Platelets - drug effects catheterization/diagnostic interventional<cardiac Clopidogrel Drug Resistance Drug Therapy, Combination Genetic Predisposition to Disease Humans myocardial infarction<ischemic heart disease Patient Selection Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests platelets Risk Assessment Risk Factors thrombosis/hypercoagulable states Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!